Two Sigma Investments, LP Intercept Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $385,793 - $722,542	38,618 Added 83.77%	84,718 $1.57 Million
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $1.73 Million - $3.65 Million	-189,191 Reduced 80.41%	46,100 $509,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $1.63 Million - $2.83 Million	130,377 Added 124.27%	235,291 $3.16 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $3.74 Million - $5.2 Million	-322,522 Reduced 75.46%	104,914 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $2.73 Million - $4.4 Million	223,282 Added 109.37%	427,436 $5.96 Million

Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $3.5 Million - $6.1 Million	-311,295 Reduced 60.39%	204,154 $2.82 Million
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $327,591 - $435,890	-24,502 Reduced 4.54%	515,449 $8.39 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $1.27 Million - $1.73 Million	88,733 Added 19.67%	539,951 $8.8 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $116,559 - $183,677	8,973 Added 2.03%	451,218 $6.7 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $4.95 Million - $7.85 Million	320,232 Added 262.46%	442,245 $8.83 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $3 Million - $5.87 Million	-155,373 Reduced 56.01%	122,013 $2.82 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $1.51 Million - $2.61 Million	61,480 Added 28.48%	277,386 $6.85 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $7.04 Million - $9.62 Million	179,993 Added 501.19%	215,906 $8.95 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $13.9 Million - $27.4 Million	-297,214 Reduced 89.22%	35,913 $1.72 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $1.54 Million - $3.78 Million	31,881 Added 10.58%	333,127 $21 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.5 Million - $3.24 Million	26,081 Added 9.48%	301,246 $37.3 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $10.6 Million - $14.6 Million	-181,411 Reduced 39.73%	275,165 $18.3 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $15.5 Million - $24 Million	198,970 Added 77.24%	456,576 $36.3 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $4.83 Million - $6.35 Million	-52,581 Reduced 16.95%	257,606 $28.8 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $7.44 Million - $11 Million	86,771 Added 38.84%	310,187 $31.3 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $19.8 Million - $28.5 Million	223,416 New	223,416 $28.2 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $1.96 Million - $2.8 Million	32,675 New	32,675 $2.74 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $5.4 Million - $6.88 Million	-102,348 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $5.96 Million - $7.45 Million	102,348	102,348 $5.98 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account